1[1]Eyre DR. The specificity of collagen cross-links as marker of bone and connective tissue degradation[J]. Acta Orthop Scand,1995,66(266):S166-170.
2[2]Stein GS,Lian JB,Owen TA. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation[J]. FASEB J,1990,4:3111-3123.
3[3]Peichl P,Griesmacher A,Muller MM,et al. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy[J]. Gynecol Endocrinol,2000,14(5):374-381.
4[4]Rotteveel J,Schoute E,Delemarre-van de Waal HA. Serum procollagen I carboxyterminal propeptide (PICP) levels through puberty: relation to height velocity and serum hormone levels[J]. Acta Paediatr,1997,86(2):143-147.
5[5]Calvo MS,Eyre DR,Grundberg CM. Molecular basis and clinical application of biological markers of bone turnover[J].Endocr Rev,1996,17:333-368.
6[6]Gertz BJ,Shao P,Hanson DA,et al. Monitoring bone resorption in early postmenopausal women by an immunoassay for crosslinked collagen peptides in wine[J]. J Bone Min Res,1994,9:135-141.
7[7]Schonau E,Rauch F. Markers of bone and collagen metabolism-problems and perspectives in paediatrics[J]. Horm Res,1997,48 (Suppl 5):50-59.
8[8]Scariano JK,Vanderjagt DJ,Thacher T,et al. Calcium supplements increase the serum levers of crosslinked N-telopeptides of bone collagen and parathyroid hormone in rachitic Nigerian children[J].Clin Biochem,1998,31(5):421-427.
9[9]Brenne RE,Schiller B,Vetter U,et al. Serum concentrations of procollagen I C-terminal propeptide,osteocalcin and insulin-like growth factor-I in patients with nonlethal osteogenesis imperfecta[J].Acta Paediatr,1993,82:764-767.
10[10]Kikuchi T,Hashimoto N,Kawasaki T,et al. Plasma levels of carboxy terminal propeptide of type I procollagen andpyridinoline cross-linked telopeptide of type I collagen in healthy schoolchildren[J]. Acta Paediatr,1998,87(8):825-829.
6Gerstenfeld LC, Shapiro FD.Experssion of bone - specific gene by hypertrophic chondrocytes: implications of the complex functions of the hypertrophic chondrocyte during endochondra bone development[J].J Cell Blochem, 1996,62(1) : 129.
8Chiodini I, Torlontano M, Camevale V, et al. Skeletal involvement in adult patients with endogenous hypercortisolism. Endocrinol Invest. 2008 Mar;31 (3) :267-276.
9Charles P, Mosekilds L, Risteli L, et al. Assessment of bone remordeling using biochemical indicators of type 1 collagen synthesis and degredation: relation to calcium kinetics [J]. Bone Miner, 1994;24:81-94.
10Kondo T, Kitazawa R, Yamaguchi A, et al. Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels. J Cell Biochem, 2008 Jan 1 ;103 (1) :335-345.
